- Home
- RLAY vs SHBI Comparison
RLAY vs SHBI Comparison
Compare RLAY & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- SHBI
- Stock Information
- Founded
- RLAY 2015
- SHBI 1876
- Country
- RLAY United States
- SHBI United States
- Employees
- RLAY N/A
- SHBI N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- SHBI Major Banks
- Sector
- RLAY Health Care
- SHBI Finance
- Exchange
- RLAY Nasdaq
- SHBI Nasdaq
- Market Cap
- RLAY 619.0M
- SHBI 532.0M
- IPO Year
- RLAY 2020
- SHBI N/A
- Fundamental
- Price
- RLAY $4.12
- SHBI $16.95
- Analyst Decision
- RLAY Strong Buy
- SHBI Buy
- Analyst Count
- RLAY 13
- SHBI 1
- Target Price
- RLAY $18.00
- SHBI $20.00
- AVG Volume (30 Days)
- RLAY 1.5M
- SHBI 121.6K
- Earning Date
- RLAY 11-05-2025
- SHBI 10-23-2025
- Dividend Yield
- RLAY N/A
- SHBI 2.83%
- EPS Growth
- RLAY N/A
- SHBI 169.45
- EPS
- RLAY N/A
- SHBI 1.61
- Revenue
- RLAY $8,355,000.00
- SHBI $208,209,000.00
- Revenue This Year
- RLAY $31.55
- SHBI N/A
- Revenue Next Year
- RLAY N/A
- SHBI $16.05
- P/E Ratio
- RLAY N/A
- SHBI $10.52
- Revenue Growth
- RLAY N/A
- SHBI 24.24
- 52 Week Low
- RLAY $1.78
- SHBI $11.47
- 52 Week High
- RLAY $10.72
- SHBI $17.61
- Technical
- Relative Strength Index (RSI)
- RLAY 65.83
- SHBI 59.10
- Support Level
- RLAY $3.52
- SHBI $16.80
- Resistance Level
- RLAY $4.26
- SHBI $17.29
- Average True Range (ATR)
- RLAY 0.22
- SHBI 0.32
- MACD
- RLAY 0.07
- SHBI 0.07
- Stochastic Oscillator
- RLAY 85.26
- SHBI 70.22
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.